Back
Devon Energy Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
21
DVN
Devon Energy
Last Price:
38.95
Seasonality Move:
2.84%
Sell
26
RARE
Ultragenyx Pharmaceutical
Last Price:
54.41
Seasonality Move:
7.55%
Sell
21
Devon Energy (DVN)
is a Sell
Is Devon Energy a Buy, Sell or Hold?
- The current Devon Energy [DVN] share price is $37.87. The Score for DVN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- DVN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $55.20. The Score for RARE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DVN Stock Price Chart
What is Devon Energy's stock price today?
-
The Devon Energy share price today is $37.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DVN is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $55.20
The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
DVN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.17 | Sell |
Relative Strength Index (14 RSI): | 26.95 | Sell |
Chaikin Money Flow: | -14733109 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.71 - 43.83) | Sell |
Bollinger Bands (100): | (42.62 - 48.68) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.09 | Buy |
Relative Strength Index (14 RSI): | 46.4 | Sell |
Chaikin Money Flow: | -343486 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.94 - 58.24) | Sell |
Bollinger Bands (100): | (40.06 - 53.94) | Buy |
DVN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.3 | Sell |
20-day SMA: | 41.08 | Sell |
50-day SMA: | 43.46 | Sell |
200-day SMA: | 46.07 | Sell |
8-day EMA: | 39.99 | Sell |
20-day EMA: | 41.05 | Sell |
50-day EMA: | 43 | Sell |
200-day EMA: | 46.17 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.58 | Sell |
20-day SMA: | 57.08 | Sell |
50-day SMA: | 52.76 | Buy |
200-day SMA: | 46.81 | Buy |
8-day EMA: | 57.09 | Sell |
20-day EMA: | 56.67 | Sell |
50-day EMA: | 53.36 | Buy |
200-day EMA: | 47.25 | Buy |
Devon Energy Earnings Growth & DVN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.33 per share, an increase next quarter of $0.24 per share, a decrease this year of $0.52 per share, and an increase next year of $0.68 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Devon Energy Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |